When patients develop a narrowing or blockage in the bile ducts—the tubes connecting the liver, gallbladder and ...

Molecular testing, including chromosomal microarray analysis, distinguishes between aggressive and indolent kidney cancer subtypes, aiding in accurate diagnosis. Accurate diagnosis is critical for ...

Now, a significant update to the National Comprehensive Cancer Network (NCCN) Clinical Practice Guidelines in Oncology is ...

Testing the molecular profile of prostate tumours identifies which patients with advanced prostate cancer are more likely to benefit from a chemotherapy treatment called docetaxel and live longer, ...

Jorge Nieva, MD, highlights the critical role of molecular testing in non–small cell lung cancer (NSCLC) care, while addressing barriers such as limited tissue samples, delayed turnaround times, and ...

Myriad Genetics, Inc. (NASDAQ: MYGN), a leader in molecular diagnostic testing and precision medicine, today announces that ...

Biomarker testing has the potential to streamline diagnosis, treatment planning, and anticipation of treatment risks, if done right.

MADISON, Wis.--(BUSINESS WIRE)--Exact Sciences Corp. (Nasdaq: EXAS), a leading provider of cancer screening and diagnostic tests, today announced that its Oncodetect™ molecular residual disease (MRD) ...

Bladder cancer arises from the lining of the bladder, the organ that stores urine, and is one of the most common cancers in ...

Fred Hutch at AACR: Colorectal cancer and glyphosate exposure, potential therapeutic targets for ovarian cancer, a new molecular standard of care for cancer patients — and more ...